These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27274165)

  • 21. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients.
    Horio T; Iwashima Y; Kamide K; Tokudome T; Yoshihara F; Nakamura S; Kawano Y
    J Hypertens; 2010 Aug; 28(8):1738-44. PubMed ID: 20485194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic Kidney Disease Increases Atrial Fibrillation Inducibility: Involvement of Inflammation, Atrial Fibrosis, and Connexins.
    Qiu H; Ji C; Liu W; Wu Y; Lu Z; Lin Q; Xue Z; Liu X; Wu H; Jiang W; Zou C
    Front Physiol; 2018; 9():1726. PubMed ID: 30564139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of atrial fibrillation development and progression: Current perspectives.
    Vlachos K; Letsas KP; Korantzopoulos P; Liu T; Georgopoulos S; Bakalakos A; Karamichalakis N; Xydonas S; Efremidis M; Sideris A
    World J Cardiol; 2016 Mar; 8(3):267-76. PubMed ID: 27022458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β
    Yamamoto S
    Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers of Atrial Fibrillation in Hypertension.
    Tsioufis C; Konstantinidis D; Nikolakopoulos I; Vemmou E; Kalos T; Georgiopoulos G; Vogiatzakis N; Ifantis A; Konstantinou K; Gennimata V; Tousoulis D
    Curr Med Chem; 2019; 26(5):888-897. PubMed ID: 28990508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.
    Castillo-Rodriguez E; Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Fernandez-Fernandez B; Kanbay M; Tejedor A; Lazaro A; Ruiz-Ortega M; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30029499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits.
    Liu T; Zhao H; Li J; Korantzopoulos P; Li G
    Cardiovasc Ther; 2014 Aug; 32(4):178-83. PubMed ID: 24814361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives.
    Nattel S; Harada M
    J Am Coll Cardiol; 2014 Jun; 63(22):2335-45. PubMed ID: 24613319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial Fibrillation in Autoimmune Rheumatic Diseases: from Pathogenesis to Treatment.
    Ciconte G; Conti M; Evangelista M; Pappone C
    Rev Recent Clin Trials; 2018; 13(3):170-175. PubMed ID: 29669504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement in estimated glomerular filtration rate in patients with chronic kidney disease undergoing catheter ablation for atrial fibrillation.
    Navaravong L; Barakat M; Burgon N; Mahnkopf C; Koopmann M; Ranjan R; Kholmovski E; Marrouche N; Akoum N
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):21-7. PubMed ID: 25142836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry.
    Deng H; Shantsila A; Xue Y; Bai Y; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Wu S; Lip GYH
    Arch Cardiovasc Dis; 2019; 112(6-7):420-429. PubMed ID: 31133543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic remodeling of intracellular Ca²⁺ signaling during atrial fibrillation.
    Greiser M; Schotten U
    J Mol Cell Cardiol; 2013 May; 58():134-42. PubMed ID: 23298712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes.
    Karam BS; Chavez-Moreno A; Koh W; Akar JG; Akar FG
    Cardiovasc Diabetol; 2017 Sep; 16(1):120. PubMed ID: 28962617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes.
    Dzeshka MS; Shahid F; Shantsila A; Lip GYH
    Am J Hypertens; 2017 Aug; 30(8):733-755. PubMed ID: 28338788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevalence and risk factors of atrial fibrillation in hospitalized patients with chronic kidney disease].
    Wang J; Chen YC; Du HA; Li XL; Mei X; Yin YH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 May; 41(5):390-3. PubMed ID: 24021121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential atrial arrhythmogenicity of adipocytes: implications for the genesis of atrial fibrillation.
    Lin YK; Chen YJ; Chen SA
    Med Hypotheses; 2010 Jun; 74(6):1026-9. PubMed ID: 20149554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lone atrial fibrillation: where are we now?
    Potpara TS; Lip GY
    Hosp Pract (1995); 2011 Oct; 39(4):17-31. PubMed ID: 22056820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial fibrillation: mechanisms, therapeutics, and future directions.
    Pellman J; Sheikh F
    Compr Physiol; 2015 Apr; 5(2):649-65. PubMed ID: 25880508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age as a Critical Determinant of Atrial Fibrillation: A Two-sided Relationship.
    Laredo M; Waldmann V; Khairy P; Nattel S
    Can J Cardiol; 2018 Nov; 34(11):1396-1406. PubMed ID: 30404745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of Atrial Fibrillation in Patients With Kidney Disease.
    Lau YC; Lip GY
    J Atr Fibrillation; 2014; 6(6):989. PubMed ID: 27957055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.